PUBLISHER: BIS Research | PRODUCT CODE: 2029917
PUBLISHER: BIS Research | PRODUCT CODE: 2029917
Asia-Pacific Transgenic Animal Model Market: Focus on Technology, Animal Type, Application, End User, and Country - Analysis and Forecast, 2025-2035
This report can be delivered in 2 working days.
Market Overview
The APAC transgenic animal model market is witnessing significant growth, driven by expanding biotechnology research, increasing pharmaceutical R&D investments, and rising demand for advanced preclinical models. The global transgenic animal model market is expected to grow steadily during the forecast period 2025-2035, with Asia-Pacific emerging as a high-growth region. Countries such as China, Japan, and India are leading this expansion due to strong government support, growing research infrastructure, and increasing focus on genomics and personalized medicine. The region's rapid adoption of gene-editing technologies and rising collaborations between academia and industry are further accelerating market growth.
| KEY MARKET STATISTICS | |
|---|---|
| Forecast Period | 2025 - 2035 |
| 2025 Evaluation | $660.2 Million |
| 2035 Forecast | $1,698.4 Million |
| CAGR | 9.91% |
The Asia-Pacific transgenic animal model market is projected to reach $1,698.4 million by 2035 from $660.2 million in 2025, growing at a CAGR of 9.91% during the forecast period 2025-2035.
Market Introduction
The APAC transgenic animal model market is becoming a key component of the region's rapidly advancing life sciences and biotechnology ecosystem. Transgenic animal models are genetically engineered organisms that carry inserted or modified genes, enabling researchers to study gene function, disease progression, and therapeutic responses. These models are widely used in drug discovery, toxicology studies, and basic biological research.
In Asia-Pacific, the demand for transgenic animal models is increasing due to the growing burden of chronic diseases, rising investments in pharmaceutical and biotechnology sectors, and the expansion of research capabilities. Countries such as China and Japan are heavily investing in genomic research and gene-editing technologies, while India is emerging as a hub for contract research and preclinical studies.
Technological advancements, particularly in CRISPR/Cas9 gene-editing, have significantly improved the efficiency and accuracy of developing transgenic models, making them more accessible and cost-effective. Additionally, the increasing focus on precision medicine and targeted therapies is driving the need for highly specialized animal models that can replicate human disease conditions.
Regulatory frameworks across APAC are evolving to support ethical research practices, although variations exist across countries. As a result, the APAC transgenic animal model market is characterized by rapid innovation, growing investments, and increasing collaboration among stakeholders.
Market Segmentation:
Segmentation 1: By Technology
- CRISPR/CAS-9
- Microinjections
- Embryonic Stem Cell Injections
- Others
Segmentation 2: By Animal Type
- Rodent (Mice & Rats)
- Rabbits
- Pigs
- Others
Segmentation 3: By Application
- Drug Discovery and Development
- Disease Research
- Gene Function Studies
- Toxicology and Safety Testing
- Others
Segmentation 4: By End User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations (CROs)
Segmentation 5: by Country
- China
- Japan
- India
- South Korea
- Australia
- Rest-of-Asia-Pacific
Market Trends, Drivers, and Challenges
Market Trends
- Rapid adoption of CRISPR/Cas9 and advanced gene-editing technologies
- Increasing focus on precision medicine and targeted therapies
- Expansion of transgenic models for oncology, neurology, and rare diseases
- Growing collaborations between academic institutions and biotech companies
Market Drivers
- Rising demand for efficient preclinical models in drug development
- Increasing investments in biotechnology and life sciences research
- Growing prevalence of chronic and genetic diseases in APAC
- Expanding pharmaceutical and CRO industries in emerging economies
Market Challenges
- Ethical concerns related to animal testing and genetic modification
- High cost and technical complexity of developing transgenic models
- Lack of standardized regulatory frameworks across APAC countries
- Limitations in replicating complex human disease conditions
How This Report Can Add Value?
Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements in transgenic animal model, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.
Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.
Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors' strengths and weaknesses and allowing them to strategize effectively to gain a competitive edge in the market.
Regulatory and Compliance Strategy: It provides updates on evolving regulatory frameworks, approvals, and industry guidelines, ensuring organizations stay compliant and accelerate market entry for new transgenic animal model products.
Investment and Business Expansion Strategy: By analyzing market trends, funding patterns, and partnership opportunities, the report assists organizations in making informed investment decisions and identifying potential M&A opportunities for business growth.
Table of Contents
Executive Summary
Scope and Definition
1 Asia-Pacific Transgenic Animal Model Market: Industry Outlook
- 1.1 Market Overview
- 1.1.1 Market Overview and Ecosystem
- 1.2 Market Trends
- 1.2.1 Impact Analysis
- 1.2.2 Rising Demand for Personalized Medicine
- 1.3 Regulatory Landscape
- 1.3.1 Asia-Pacific
- 1.3.1.1 China
- 1.3.1.2 Japan
- 1.3.1 Asia-Pacific
- 1.4 Pricing Analysis
- 1.4.1 Generation Costs (Creating New Models)
- 1.4.2 Acquisition Costs (Purchasing Existing Models)
- 1.4.3 Additional Costs
- 1.5 Technology Landscape
- 1.6 Market Dynamics
- 1.6.1 Drivers, Challenges, and Opportunities: Current and Future Impact Assessment
- 1.6.2 Market Drivers
- 1.6.2.1 Growing Number of Pharmaceutical Research and Drug Development Activities
- 1.6.2.2 Technological Advancements in Genetic Engineering
- 1.6.2.3 Increasing Demand for Advanced Disease Models for Drug Discovery
- 1.6.3 Market Restraints
- 1.6.3.1 High Maintenance Cost of Animal Models
- 1.6.3.2 Strict Regulations and Guidelines
- 1.6.4 Market Opportunities
- 1.6.4.1 Emergence of CRISPR as a Powerful Tool for Biomedical Research Field
- 1.6.4.2 Increasing Demand for Disease-Specific Models
2 Region
- 2.1 Regional Summary
- 2.2 Asia Pacific
- 2.2.1 Regional Overview
- 2.2.2 Driving Factors for Market Growth
- 2.2.3 Factors Challenging the Market
- 2.2.4 Market Sizing and Forecast
- 2.2.4.1 Asia Pacific Transgenic Animal Model Market, by Technology
- 2.2.4.2 Asia Pacific Transgenic Animal Model Market, by Animal Type
- 2.2.4.3 Asia Pacific Transgenic Animal Model Market, by Application
- 2.2.4.4 Asia Pacific Transgenic Animal Model Market, by End User
- 2.2.4.5 Asia PacificTransgenic Animal Model Market, by Country
- 2.2.5 China
- 2.2.5.1 Country Overview
- 2.2.5.2 China Transgenic Animal Model Market, by Technology
- 2.2.5.3 China Transgenic Animal Model Market, by Animal Type
- 2.2.5.4 China Transgenic Animal Model Market, by Application
- 2.2.5.5 China Transgenic Animal Model Market, by End User
- 2.2.6 Japan
- 2.2.6.1 Country Overview
- 2.2.6.2 Japan Transgenic Animal Model Market, by Technology
- 2.2.6.3 Japan Transgenic Animal Model Market, by Animal Type
- 2.2.6.4 Japan Transgenic Animal Model Market, by Application
- 2.2.6.5 Japan Transgenic Animal Model Market, by End User
- 2.2.7 India
- 2.2.7.1 Country Overview
- 2.2.7.2 India Transgenic Animal Model Market, by Technology
- 2.2.7.3 India Transgenic Animal Model Market, by Animal Type
- 2.2.7.4 India Transgenic Animal Model Market, by Application
- 2.2.7.5 India Transgenic Animal Model Market, by End User
- 2.2.8 Australia
- 2.2.8.1 Country Overview
- 2.2.8.2 Australia Transgenic Animal Model Market, by Technology
- 2.2.8.3 Australia Transgenic Animal Model Market, by Animal Type
- 2.2.8.4 Australia Transgenic Animal Model Market, by Application
- 2.2.8.5 Australia Transgenic Animal Model Market, by End User
- 2.2.9 South Korea
- 2.2.9.1 Country Overview
- 2.2.9.2 South Korea Transgenic Animal Model Market, by Technology
- 2.2.9.3 South Korea Transgenic Animal Model Market, by Animal Type
- 2.2.9.4 South Korea Transgenic Animal Model Market, by Application
- 2.2.9.5 South Korea Transgenic Animal Model Market, by End User
- 2.2.10 Rest-of-the- Asia Pacific
- 2.2.10.1 Country Overview
- 2.2.10.2 Rest of the Asia Pacific Transgenic Animal Model Market, by Technology
- 2.2.10.3 Rest of the Asia Pacific Transgenic Animal Model Market, by Animal Type
- 2.2.10.4 Rest of the Asia Pacific Transgenic Animal Model Market, by Application
- 2.2.10.5 Rest of the Asia Pacific Transgenic Animal Model Market, by End User
3 Competitive Benchmarking and Company Profiles
- 3.1 Company Profiles
- 3.1.1 HuidaGene
- 3.1.1.1 Overview
- 3.1.1 HuidaGene
4 Research Methodology
- 4.1 Data Sources
- 4.1.1 Primary Data Sources
- 4.1.2 Secondary Data Sources
- 4.1.3 Inclusion and Exclusion
- 4.1.4 Data Triangulation
- 4.2 Market Estimation and Forecast
List of Figures
- Figure 1: Asia-Pacific Transgenic Animal Model Market (by Scenario), $Million, 2024, 2028, and 2035
- Figure 2: Asia-Pacific Transgenic Animal Model Market, 2024 and 2035
- Figure 3: Asia-Pacific Transgenic Animal Model Market Snapshot
- Figure 4: Transgenic Animal Model Market, $Million, 2024 and 2035
- Figure 5: Asia-Pacific Transgenic Animal Model Market (by Technology), $Million, 2024, 2028, and 2035
- Figure 6: Asia-Pacific Transgenic Animal Model Market (by Animal Type), $Million, 2024, 2028, and 2035
- Figure 7: Asia-Pacific Transgenic Animal Model Market (by Application), $Million, 2024, 2028, and 2035
- Figure 8: Asia-Pacific Transgenic Animal Model Market (by End User), $Million, 2024, 2028, and 2035
- Figure 9: Key Stakeholders of Transgenic Animal Model Market
- Figure 10: Transgenic Animals: Timeline of Key Events
- Figure 11: Role of Humanized Mouse Models in Development of New Precision and Personalized Medicine Strategies
- Figure 12: Evolution of Transgenic Technologies
- Figure 13: Drug Development Pipeline, 2019 and 2024
- Figure 14: Major Technical Advances in Genome Editing and Delivery in Mice and Rats from 1980s to 2020s
- Figure 15: Asia Pacific Transgenic Animal Model Market, $Million, 2024-2035
- Figure 16: Inclusion and Exclusion Criteria for Transgenic Animal Model Market
- Figure 17: Data Triangulation
- Figure 18: Top-Down and Bottom-Up Approach
- Figure 19: Assumptions and Limitations
List of Tables
- Table 1: Market Snapshot
- Table 2: Cost of Generating New Transgenic Animals
- Table 3: Cost of Purchasing Existing Models
- Table 4: Additional Costs
- Table 5: Transgenic Animal Model Market (by Region), $Million, 2024-2035
- Table 6: Asia Pacific Transgenic Animal Model Market (by Technology), $Million, 2024-2035
- Table 7: Asia Pacific Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
- Table 8: Asia Pacific Transgenic Animal Model Market (by Application), $Million, 2024-2035
- Table 9: Asia Pacific Transgenic Animal Model Market (by End User), $Million, 2024-2035
- Table 10: Asia Pacific Transgenic Animal Model Market (by Country), $Million, 2024-2035
- Table 11: China Transgenic Animal Model Market (by Technology), $Million, 2024-2035
- Table 12: China Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
- Table 13: China Transgenic Animal Model Market (by Application), $Million, 2024-2035
- Table 14: China Transgenic Animal Model Market (by End User), $Million, 2024-2035
- Table 15: Japan Transgenic Animal Model Market (by Technology), $Million, 2024-2035
- Table 16: Japan Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
- Table 17: Japan Transgenic Animal Model Market (by Application), $Million, 2024-2035
- Table 18: Japan Transgenic Animal Model Market (by End User), $Million, 2024-2035
- Table 19: India Transgenic Animal Model Market (by Technology), $Million, 2024-2035
- Table 20: India Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
- Table 21: India Transgenic Animal Model Market (by Application), $Million, 2024-2035
- Table 22: India Transgenic Animal Model Market (by End User), $Million, 2024-2035
- Table 23: Australia Transgenic Animal Model Market (by Technology), $Million, 2024-2035
- Table 24: Australia Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
- Table 25: Australia Transgenic Animal Model Market (by Application), $Million, 2024-2035
- Table 26: Australia Transgenic Animal Model Market (by End User), $Million, 2024-2035
- Table 27: South Korea Transgenic Animal Model Market (by Technology), $Million, 2024-2035
- Table 28: South Korea Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
- Table 29: South Korea Transgenic Animal Model Market (by Application), $Million, 2024-2035
- Table 30: South Korea Transgenic Animal Model Market (by End User), $Million, 2024-2035
- Table 31: Rest of the Asia Pacific Transgenic Animal Model Market (by Technology), $Million, 2024-2035
- Table 32: Rest of the Asia Pacific Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
- Table 33: Rest of the Asia Pacific Transgenic Animal Model Market (by Application), $Million, 2024-2035
- Table 34: Rest of the Asia Pacific Transgenic Animal Model Market (by End User), $Million, 2024-2035
